---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-23-042817"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2023-12-28T23:59:59+00:00"
generated_at: "2026-06-07T06:21:06.542007+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Avalo Therapeutics executes 1-for-240 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective 5:00 PM ET Dec 28, 2023; shares trade split-adjusted Dec 29 under AVTX.
- Shares outstanding reduced from ~192.4M to ~801,611; fractional shares rounded up to whole share.
- Split raises per-share price to satisfy Nasdaq Capital Market minimum bid price rule.
- No change to authorized shares or par value; options/warrants adjusted proportionally.
- New CUSIP 05338F306; Equiniti Trust Company acting as exchange agent.

## SEC filing metadata
- accession: 0001628280-23-042817
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2023-12-28T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828023042817/0001628280-23-042817-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828023042817/avtx-20231228.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-23-042817
- JSON: https://secwatch.observer/filing/0001628280-23-042817.json
- Plain text: https://secwatch.observer/filing/0001628280-23-042817.txt

## Key facts
- Governance Changes
  Avalo Therapeutics, Inc.: Effected a reverse stock split at a ratio of 1-for-240 shares of common stock (effective 2023-12-28).
  - Change: charter amendment
  - Effective: 2023-12-28
  source text: Avalo Therapeutics, Inc. (the “Company”) filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, as amended (the “Certificate of Amendment”), with the Secretary of State of Delaware for the purpose of effecting a reverse stock split (the “Reverse Stock Split”) of the outstanding shares of the Company’s common stock at a ratio of one (1) share for every two hundred forty (240) shares outstanding
  evidence_url: https://www.sec.gov/Archives/edgar/data/1534120/000162828023042817/0001628280-23-042817-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.